Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NEUROPROTECTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Name | NEUROPROTECTION |
| Key Genes/Proteins | Aucubin |
| Related Diseases | NEURODEGENERATION |
Knowledge base pages for this entity
graph TD
NEUROPROTECTION["NEUROPROTECTION"]
style NEUROPROTECTION fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
NEUROPROTECTION -.->|"protects against"| Glaucoma["Glaucoma"]
NEUROPROTECTION -.->|"protects against"| Neurodegeneration["Neurodegeneration"]
NEUROPROTECTION -.->|"protects against"| Axonal_Damage(Axonal Damage)
NEUROPROTECTION -.->|"protects against"| major_depressive_disorder["major depressive disorder"]
NEUROPROTECTION -.->|"inhibits"| NEURODEGENERATION(NEURODEGENERATION)
NEUROPROTECTION -.->|"protects against"| PPAR["PPAR"]
NEUROPROTECTION -.->|"protects against"| VDR["VDR"]
NEUROPROTECTION -.->|"protects against"| PARKIN["PARKIN"]
NEUROPROTECTION -->|"activates"| NRF2["NRF2"]
Connexin43_Hemichannel_Blockad["Connexin43 Hemichannel Blockade"] -->|"mediates"| NEUROPROTECTION
MT1([MT1]) -->|"involved_in"| NEUROPROTECTION
MT2([MT2]) -->|"involved_in"| NEUROPROTECTION
Tudca["Tudca"] -->|"mediates"| NEUROPROTECTION
AKT([AKT]) -->|"involved_in"| NEUROPROTECTION
METALLOTHIONEIN([METALLOTHIONEIN]) -->|"mediates"| NEUROPROTECTION
METALLOTHIONEIN_I_II([METALLOTHIONEIN-I+II]) -->|"involved_in"| NEUROPROTECTION
PPARG["PPARG"] -->|"mediates"| NEUROPROTECTION
BDNF_TrkB_signaling["BDNF/TrkB signaling"] -->|"promotes"| NEUROPROTECTION
microglial_APOE4_deletion["microglial APOE4 deletion"] -->|"promotes"| NEUROPROTECTION| Target | Relation | Type | Str |
|---|---|---|---|
| Glaucoma | protects_against | disease | 0.85 |
| Neurodegeneration | protects_against | process | 0.85 |
| Axonal Damage | protects_against | phenotype | 0.85 |
| major depressive disorder | protects_against | disease | 0.80 |
| Alzheimer's Disease | protects_against | disease | 0.75 |
| NEURODEGENERATION | inhibits | phenotype | 0.64 |
| PPAR | protects_against | entity | 0.60 |
| PPAR | activates | entity | 0.60 |
| VDR | protects_against | entity | 0.60 |
| PARKIN | protects_against | entity | 0.60 |
| NRF2 | activates | entity | 0.60 |
| PI3K | activates | entity | 0.60 |
| SLC7A11 | activates | entity | 0.60 |
| STROKE | protects_against | entity | 0.60 |
| NLGN3 | activates | entity | 0.60 |
| STROKE | biomarker_for | entity | 0.60 |
| NRF2 | inhibits | entity | 0.60 |
| SLC7A11 | inhibits | entity | 0.60 |
| STROKE | inhibits | entity | 0.60 |
| MAPK SIGNALING | activates | concept | 0.50 |
| CENTRAL NERVOUS SYSTEM | protects_against | concept | 0.50 |
| ISCHEMIC STROKE | protects_against | concept | 0.50 |
| ISCHEMIC STROKE | inhibits | concept | 0.50 |
| IGF-1 | activates | concept | 0.50 |
| ISCHEMIC STROKE | activates | concept | 0.50 |
| MICROGLIAL ACTIVATION | activates | concept | 0.50 |
| QUERCETIN | interacts_with | concept | 0.50 |
| GLIOSIS | activates | concept | 0.50 |
| CENTRAL NERVOUS SYSTEM | activates | concept | 0.50 |
| REMYELINATION | inhibits | concept | 0.50 |
| PI3K/AKT SIGNALING | activates | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Tudca | mediates | compound | 0.95 |
| MT2 | involved_in | protein | 0.95 |
| AKT | involved_in | protein | 0.95 |
| MT1 | involved_in | protein | 0.95 |
| METALLOTHIONEIN | mediates | protein | 0.95 |
| Connexin43 Hemichannel Blockade | mediates | mechanism | 0.95 |
| METALLOTHIONEIN-I+II | involved_in | protein | 0.95 |
| BDNF/TrkB signaling | promotes | pathway | 0.92 |
| microglial APOE4 deletion | promotes | process | 0.91 |
| INTESTINAL NHR-86 | mediates | protein | 0.90 |
| NO | mediates | compound | 0.90 |
| Cerebral Insulin Signaling | mediates | pathway | 0.90 |
| Methylene Blue | promotes | drug | 0.90 |
| Astrocytes | mediates | cell_type | 0.90 |
| Connexin43 Hemichannel Blockade | activates | mechanism | 0.90 |
| Berberine-Inspired Ionizable Lipid | promotes | compound | 0.90 |
| Gd3 Synthase | mediates | enzyme | 0.90 |
| GJA1 | modulates | protein | 0.90 |
| Microglia | mediates | cell_type | 0.90 |
| TGR5 | mediates | receptor | 0.90 |
| APOE4 | suppresses | gene | 0.88 |
| Atremorine | mediates | compound | 0.88 |
| mitophagy | promotes | process | 0.88 |
| BDNF | mediates | gene | 0.88 |
| Hk2-Pink1 Pathway | mediates | pathway | 0.88 |
| mitophagy enhancement | promotes | process | 0.87 |
| Hk2-Pink1 | promotes | pathway | 0.85 |
| A2 Astrocytes | mediates | cell_type | 0.85 |
| PRKN | mediates | protein | 0.85 |
| Mitochondrial Homeostasis | involved_in | process | 0.85 |
| SHH signaling pathway | mediates | pathway | 0.85 |
| BDNF | promotes | gene | 0.85 |
| MAPK Signaling Pathway | mediates | pathway | 0.85 |
| PRKN | protects_against | protein | 0.85 |
| NFE2L2 | mediates | gene | 0.85 |
| Pi3K/Akt Pathway | mediates | pathway | 0.85 |
| Antioxidant Enzymatic Systems | involved_in | pathway | 0.85 |
| AMPK | mediates | protein | 0.85 |
| lncRNAs | mediates | biomarker | 0.85 |
| APOE Ε4 | inhibits | protein | 0.85 |
| Polyphenols | mediates | compound | 0.85 |
| HK2-PINK1 pathway | promotes | pathway | 0.85 |
| Tryptophan Metabolites | mediates | compound | 0.85 |
| Macrophage/Microglia Autophagy | protects_against | process | 0.85 |
| HDAC3 Inhibition | mediates | mechanism | 0.85 |
| Exosome-Based Treatments | promotes | drug | 0.85 |
| STING Inhibition | protects_against | mechanism | 0.85 |
| PPARGC1A | mediates | gene | 0.85 |
| MicroRNAs | mediates | biomarker | 0.85 |
| Long Non-Coding RNAs | mediates | biomarker | 0.85 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 0 hypotheses
neurodegeneration | 2026-04-10 | 0 hypotheses
neurodegeneration | 2026-04-02 | 4 hypotheses Top: 0.720
neurodegeneration | 2026-04-01 | 20 hypotheses Top: 0.888
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.82 · 2026-04-22
closed · Rounds: 0 · Score: 0.66 · 2026-04-21
closed · Rounds: 0 · Score: 0.64 · 2026-04-21
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.95 · 2026-04-01